Bilateral Facial Nerve Palsy associated with COVID‐19 and Epstein‐Barr Virus co‐infection

Cabrera Muras, Antonio; Carmona‐Abellán, María del Mar; Collía Fernández, Alejandra; Uterga Valiente, Juan María; Antón Méndez, Lander; García‐Moncó, Juan Carlos

A 20‐year‐old male, with no relevant previous medical history, was admitted due to bilateral facial weakness. Two weeks before, he noticed odynophagia and fever of 39ºC without cough. He associated significant asthenia with headache, myalgia, nausea, and vomiting and he was treated with levofloxacin 500mg qd for 7 days. One week after, during an initial improvement of the respiratory symptoms, he presented acute right facial weakness. He was diagnosed with right peripheral facial palsy and was treated with prednisone 60 mg/24h with a tapering schedule.